Literature DB >> 20215563

Size, shape, and stamina: the impact of left ventricular geometry on exercise capacity.

Carolyn S P Lam1, Jasmine Grewal, Barry A Borlaug, Steve R Ommen, Garvan C Kane, Robert B McCully, Patricia A Pellikka.   

Abstract

Although several studies have examined the cardiac functional determinants of exercise capacity, few have investigated the effects of structural remodeling. The current study evaluated the association between cardiac geometry and exercise capacity. Subjects with ejection fraction > or = 50% and no valvular disease, myocardial ischemia, or arrhythmias were identified from a large prospective exercise echocardiography database. Left ventricular mass index and relative wall thickness were used to classify geometry into normal, concentric remodeling, eccentric hypertrophy, and concentric hypertrophy. All of the subjects underwent symptom-limited treadmill exercise according to standard Bruce protocol. Maximal exercise tolerance was measured in metabolic equivalents. Of 366 (60+/-14 years; 57% male) subjects, 166 (45%) had normal geometry, 106 (29%) had concentric remodeling, 40 (11%) had eccentric hypertrophy, and 54 (15%) had concentric hypertrophy. Geometry was related to exercise capacity: in descending order, the maximum achieved metabolic equivalents were 9.9+/-2.8 in normal, 8.9+/-2.6 in concentric remodeling, 8.6+/-3.1 in eccentric hypertrophy, and 8.0+/-2.7 in concentric hypertrophy (all P<0.02 versus normal). Left ventricular mass index and relative wall thickness were negatively correlated with exercise tolerance in metabolic equivalents (r=-0.14; P=0.009 and r=-0.21; P<0.001, respectively). Augmentation of heart rate and ejection fraction with exercise were blunted in concentric hypertrophy compared with normal, even after adjusting for medications. In conclusion, the pattern of ventricular remodeling is related to exercise capacity among low-risk adults. Subjects with concentric hypertrophy display the greatest limitation, and this is related to reduced systolic and chronotropic reserve. Reverse remodeling strategies may prevent or treat functional decline in patients with structural heart disease.

Entities:  

Mesh:

Year:  2010        PMID: 20215563      PMCID: PMC2856936          DOI: 10.1161/HYPERTENSIONAHA.109.146845

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  39 in total

1.  Longitudinal association of ambulatory pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension.

Authors:  R S Khattar; D U Acharya; C Kinsey; R Senior; A Lahiri
Journal:  J Hypertens       Date:  1997-07       Impact factor: 4.844

2.  Prospective studies on left ventricular geometric patterns and exercise tolerance in unmedicated men with borderline and mild hypertension.

Authors:  H Tomiyama; N Doba; T Kushiro; M Yamashita; K Kanmatsuse; N Kajiwara; H Yoshida; S Hinohara
Journal:  J Hypertens       Date:  1996-10       Impact factor: 4.844

3.  Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy.

Authors:  G P Aurigemma; K H Silver; M A Priest; W H Gaasch
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

4.  Two-dimensional echocardiographic measurement of left ventricular ejection fraction: prospective analysis of what constitutes an adequate determination.

Authors:  R B Stamm; B A Carabello; D L Mayers; R P Martin
Journal:  Am Heart J       Date:  1982-07       Impact factor: 4.749

5.  A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.

Authors:  M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

6.  Resting diastolic function and left ventricular mass are related to exercise capacity in hypertensive men but not in women.

Authors:  A G Gharavi; J A Diamond; A Y Goldman; N L Coplan; J S Jhang; M Steinmetz; R Goldsmith; R A Phillips
Journal:  Am J Hypertens       Date:  1998-10       Impact factor: 2.689

7.  Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension.

Authors:  A Ganau; R B Devereux; M J Roman; G de Simone; T G Pickering; P S Saba; P Vargiu; I Simongini; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

8.  What is normal blood pressure? Comparison of ambulatory pressure level and variability in patients with normal or abnormal left ventricular geometry.

Authors:  R B Devereux; G D James; T G Pickering
Journal:  Am J Hypertens       Date:  1993-06       Impact factor: 2.689

9.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

Review 10.  Nomogram based on metabolic equivalents and age for assessing aerobic exercise capacity in men.

Authors:  C K Morris; J Myers; V F Froelicher; T Kawaguchi; K Ueshima; A Hideg
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

View more
  13 in total

1.  Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal Study.

Authors:  Stephanie K Brinker; Ambarish Pandey; Colby R Ayers; Carolyn E Barlow; Laura F DeFina; Benjamin L Willis; Nina B Radford; Ramin Farzaneh-Far; James A de Lemos; Mark H Drazner; Jarett D Berry
Journal:  JACC Heart Fail       Date:  2014-04-30       Impact factor: 12.035

2.  Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation.

Authors:  Eugenia Raichlin; Malik A Al-Omari; Courtney L Hayes; Brooks S Edwards; Robert P Frantz; Barry A Boilson; Alfredo L Clavell; Richard J Rodeheffer; John A Schirger; Sudhir S Kushwaha; Thomas G Allison; Naveen L Pereira
Journal:  J Heart Lung Transplant       Date:  2011-05-31       Impact factor: 10.247

Review 3.  Myocardial remodeling: cellular and extracellular events and targets.

Authors:  Jennifer A Dixon; Francis G Spinale
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

Review 4.  Diastolic stress test for the evaluation of exertional dyspnea.

Authors:  Garvan C Kane; Jae K Oh
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 5.  Diastolic Stress Testing Along the Heart Failure Continuum.

Authors:  T Jake Samuel; Rhys Beaudry; Satyam Sarma; Vlad Zaha; Mark J Haykowsky; Michael D Nelson
Journal:  Curr Heart Fail Rep       Date:  2018-12

6.  Mice lacking α-, β1- and β2-syntrophins exhibit diminished function and reduced dystrophin expression in both cardiac and skeletal muscle.

Authors:  Min Jeong Kim; Nicholas P Whitehead; Kenneth L Bible; Marvin E Adams; Stanley C Froehner
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

Review 7.  Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.

Authors:  Frank R Heinzel; Felix Hohendanner; Ge Jin; Simon Sedej; Frank Edelmann
Journal:  J Appl Physiol (1985)       Date:  2015-07-16

8.  Fitness in Young Adulthood and Long-Term Cardiac Structure and Function: The CARDIA Study.

Authors:  Ambarish Pandey; Norrina B Allen; Colby Ayers; Jared P Reis; Henrique T Moreira; Stephen Sidney; Jamal S Rana; David R Jacobs; Lisa S Chow; James A de Lemos; Mercedes Carnethon; Jarett D Berry
Journal:  JACC Heart Fail       Date:  2017-03-08       Impact factor: 12.544

9.  Left Ventricular Remodeling and Myocardial Work: Results From the Population-Based STAAB Cohort Study.

Authors:  Floran Sahiti; Caroline Morbach; Vladimir Cejka; Judith Albert; Felizitas A Eichner; Götz Gelbrich; Peter U Heuschmann; Stefan Störk
Journal:  Front Cardiovasc Med       Date:  2021-06-11

10.  Diagnosis and management of pulmonary hypertension associated with left ventricular diastolic dysfunction.

Authors:  Vinicio A de Jesus Perez; Francois Haddad; Roham T Zamanian
Journal:  Pulm Circ       Date:  2012 Apr-Jun       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.